col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


176 Results       Page 1

 [1] 
American Society for Clinical Investigation: Journal of Clinical Investigation
  original article Date Title Authors   All Authors
1 [GO] 2025―Jan―14 Sequential intranasal booster triggers class switching from intramuscularly primed IgG to mucosal IgA against SARS-CoV-2 Yifan Lin, Xuejiao Liao, Xuezhi Cao, Zhaoyong Zhang, Xiuye Wang, Xiaomeng He, et al. (+12)
2 [GO] 2025―Jan―07 CXCL12 ameliorates neutrophilia and disease severity in SARS-CoV-2 infection Jian Zheng, Hima Dhakal, Enya Qing, Rejeena Shrestha, Anne E. Geller, Samantha M. Morrissey, et al. (+20)
3 [GO] 2024―Dec―17 Long COVID is associated with lower percentages of mature, cytotoxic NK cell phenotypes Tasha Tsao, Amanda M. Buck, Lilian Grimbert, Brian H. LaFranchi, Belen Altamirano Poblano, Emily A. Fehrman, et al. (+9)
4 [GO] 2024―Nov―26 Structural characterization of human monoclonal antibodies targeting uncommon antigenic sites on spike glycoprotein of SARS-CoV Naveenchandra Suryadevara, Nurgun Kose, Sandhya Bangaru, Elad Binshtein, Jennifer Munt, David R. Martinez, et al. (+7)
5 [GO] 2024―Oct―14 Neutralizing activity of anti-SARS-CoV-2 hyperimmune immunoglobulins and intravenous immunoglobulins against currently circulating SARS-CoV-2 variants Lorenza Bellusci, Hana Golding, Surender Khurana
6 [GO] 2024―Sep―12 A six-year study in a real-world population reveals an increased incidence of dyslipidemia during COVID-19 Valentina Trimarco, Raffaele Izzo, Stanislovas S. Jankauskas, Mario Fordellone, Giuseppe Signoriello, Maria Virginia Manzi, et al. (+11)
7 [GO] 2024―Aug―14 The forgotten pandemic: how understanding cholera illuminated mechanisms of chloride channels in multiple diseases Qais Al-Awqati
8 [GO] 2024―Jul―11 Randomised controlled trial reveals no benefit to a 3-month delay in COVID-19 mRNA booster vaccine Wen Shi Lee, Jennifer Audsley, Mai-Chi Trieu, Arnold Reynaldi, L. Carissa Aurelia, Palak H. Mehta, et al. (+15)
9 [GO] 2024―Jun―30 The other pandemic: lessons from 40 years of HIV research Mary E. Klotman, Barton F. Haynes
10 [GO] 2024―Apr―30 Integrated longitudinal multiomics study identifies immune programs associated with acute COVID-19 severity and mortality Jeremy P. Gygi, Cole Maguire, Ravi K. Patel, Pramod Shinde, Anna Konstorum, Casey P. Shannon, et al. (+37)
11 [GO] 2024―Mar―31 Pandemics past, present, and future: progress and persistent risks Arturo Casadevall
12 [GO] 2024―Mar―14 Contralateral versus ipsilateral vaccine boosting for COVID-19: considering the broader scientific landscape Paul Goepfert
13 [GO] 2024―Mar―14 Evolution of nasal and olfactory infection characteristics of SARS-CoV-2 variants Mengfei Chen, Andrew Pekosz, Jason S. Villano, Wenjuan Shen, Ruifeng Zhou, Heather Kulaga, et al. (+9)
14 [GO] 2023―Nov―30 High-frequency home self-collection of capillary blood correlates IFI27 expression kinetics with SARS-CoV-2 viral clearance Fang Yun Lim, Soo-Young Kim, Karisma N. Kulkarni, Rachel L. Blazevic, Louise E. Kimball, Hannah G. Lea, et al. (+9)
15 [GO] 2023―Nov―15 Cells that survive acute murine SARS-CoV-2 infection are detected nearly exclusively in the respiratory tract Ruangang Pan, David K. Meyerholz, Stanley Perlman
16 [GO] 2023―Oct―10 SARS-CoV2 mRNA-vaccination-induced immunological memory in human non-lymphoid and lymphoid tissues Vanessa Proß, Arne Sattler, Söeren Lukassen, Laura Tóth, Linda Marie Laura Thole, Janine Siegle, et al. (+29)
17 [GO] 2023―Sep―05 Vaccine effectiveness of BNT162b2 mRNA Covid-19 vaccine in children under 5 years Christoph Strumann, Otavio T. Ranzani, Jeanne Moor, Reinhard Berner, Nicole Toepfner, Cho-Ming Chao, Matthias B. Moor
18 [GO] 2023―Aug―15 Adverse outcomes in SARS-CoV-2 infected pregnant mice are gestational age-dependent and resolve with antiviral treatment Patrick S. Creisher, Jamie L. Perry, Weizhi Zhong, Jun Lei, Kathleen R. Mulka, W. Hurley Ryan, et al. (+7)
19 [GO] 2023―Aug―10 Mast cell activation in lungs during SARS-CoV-2 infection associated with lung pathology and severe COVID-19 Janessa Yan Jun Tan, Danielle E. Anderson, Abhay P.S. Rathore, Aled O'Neill, Chinmay Kumar Mantri, Wilfried A.A. Saron, et al. (+13)
20 [GO] 2023―Jul―20 No evidence of durable trained immunity after two doses of adenovirus-vectored or mRNA COVID-19 vaccines Natalie E. Stevens, Feargal J. Ryan, Nicole L. Messina, Stephen J. Blake, Todd S. Norton, Susie Germano, et al. (+8)
21 [GO] 2023―May―23 Prevalence and functional profile of SARS-CoV-2 T cells in asymptomatic Kenyan adults Taraz Samandari, Joshua Ongalo, Kimberly McCarthy, Richard K. Biegon, Philister Madiega, Anne Mithika, et al. (+15)
22 [GO] 2023―Apr―27 Machine learning links unresolving secondary pneumonia to mortality in patients with severe pneumonia, including COVID-19 Catherine A. Gao, Nikolay S. Markov, Thomas Stoeger, Anna E. Pawlowski, Mengjia Kang, Prasanth Nannapaneni, et al. (+14)
23 [GO] 2023―Apr―27 C5aR1 signaling triggers lung immunopathology in COVID-19 through neutrophil extracellular traps Bruna M.S. Silva, Giovanni F. Gomes, Flavio P. Veras, Seppe Cambier, Gabriel V.L. Silva, Andreza U. Quadros, et al. (+38)
24 [GO] 2023―Apr―16 Does the SARS-CoV-2 spike really have an Achilles heel? Shiv Pillai
25 [GO] 2023―Apr―13 Biological rhythms in COVID-19 vaccine effectiveness in an observational cohort study of 1.5 million patients Guy Hazan, Or A. Duek, Hillel Alapi, Huram Mok, Alexander T. Ganninger, Elaine M. Ostendorf, et al. (+4)
26 [GO] 2023―Mar―23 Durability of immune responses to the booster mRNA vaccination against COVID-19 Prabhu S Arunachalam, Lilin Lai, Hady Samaha, Yupeng Feng, Mengyun Hu, Harold Sai-yin Hui, et al. (+15)
27 [GO] 2023―Mar―14 SARS-CoV-2 variants resistant to monoclonal antibodies in immunocompromised patients is a public health concern Arturo Casadevall, Daniele Focosi
28 [GO] 2023―Mar―02 Site of vulnerability on SARS-CoV-2 spike induces broadly protective antibody to antigenically distinct Omicron subvariants Siriruk Changrob, Peter J. Halfmann, Hejun Liu, Jonathan L. Torres, Joshua J.C. McGrath, Gabriel Ozorowski, et al. (+21)
29 [GO] 2023―Feb―23 Therapeutic potential of convalescent plasma and SARS-CoV-2 hyperimmune immunoglobulins against BQ.1, BQ.1.1 and XBB variants Lorenza Bellusci, Hana Golding, Surender Khurana
30 [GO] 2023―Feb―02 Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments Akshita Gupta, Angelina Konnova, Mathias Smet, Matilda Berkell, Alessia Savoldi, Matteo Morra, et al. (+10)
31 [GO] 2023―Jan―31 Unlocking life-threatening COVID-19 through two types of inborn errors of type I IFNs Jean-Laurent Casanova, Mark S. Anderson
32 [GO] 2023―Jan―16 Beyond adaptive immunity: induction of trained immunity by COVID-19 adenoviral vaccines Mihai G. Netea, Leo A.B. Joosten
33 [GO] 2023―Jan―02 Impact of antigenic evolution and original antigenic sin on SARS-CoV-2 immunity Muriel Aguilar-Bretones, Ron A.M. Fouchier, Marion P.G. Koopmans, Gijsbert P. van Nierop
34 [GO] 2022―Dec―01 Impact of pre-existing chronic viral infection and reactivation on the development of long COVID Michael J. Peluso, Tyler-Marie Deveau, Sadie E. Munter, Dylan M. Ryder, Amanda M. Buck, Gabriele Beck-Engeser, et al. (+26)
35 [GO] 2022―Nov―30 Omicron infection elicits a broad neutralizing response in hospitalized patients with COVID-19 Elizabeth M. McNally
36 [GO] 2022―Nov―03 One-year follow-up of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients Sixten Körper, Beate Grüner, Daniel Zickler, Thomas Wiesmann, Patrick Wuchter, Rainer Blasczyk, et al. (+34)
37 [GO] 2022―Oct―27 Stabilized recombinant SARS-CoV-2 spike antigen enhances vaccine immunogenicity and protective capacity Christian Meyer zu Natrup, Alina Tscherne, Christine Dahlke, Malgorzata Ciurkiewicz, Dai-Lun Shin, Anahita Fathi, et al. (+27)
38 [GO] 2022―Oct―25 Trained immunity is induced in humans after immunization with an adenoviral vector COVID-19 vaccine Dearbhla M. Murphy, Donal J. Cox, Sarah A. Connolly, Eamon P Breen, Aenea A.I. Brugman, James J. Phelan, et al. (+2)
39 [GO] 2022―Oct―25 The Notch1/CD22 signaling axis disrupts Treg cell function in SARS-CoV2-associated multisystem inflammatory syndrome in children Mehdi Benamar, Qian Chen, Janet Chou, Amélie M. Julé, Rafik Boudra, Paola Contini, et al. (+44)
40 [GO] 2022―Oct―20 Rapalogs downmodulate intrinsic immunity and promote cell entry of SARS-CoV-2 Guoli Shi, Abhilash I. Chiramel, Tiansheng Li, Kin Kui Lai, Adam D. Kenney, Ashley Zani, et al. (+10)
41 [GO] 2022―Oct―18 Neutralizing antibody responses in patients hospitalized with SARS-CoV-2 Delta or Omicron infection Susanne L. Linderman, Lilin Lai, Estefany L. Bocangel Gamarra, Max S.Y. Lau, Srilatha Edupuganti, Diya Surie, et al. (+16)
42 [GO] 2022―Oct―11 Improved control of SARS-CoV-2 by treatment with nucleocapsid-specific monoclonal antibody Tanushree Dangi, Sarah Sanchez, Jacob Class, Michelle C. Richner, Lavanya Visvabharathy, Young Rock Chung, et al. (+5)
43 [GO] 2022―Sep―27 Recognizing the importance of COVID-19 data wrangling Laura J. Rasmussen-Torvik
44 [GO] 2022―Sep―14 Durability of protection and immunogenicity of AZD1222 (ChAdOx1 nCoV-19) COVID-19 vaccine over 6 months Magdalena E. Sobieszczyk, Jill Maaske, Ann R. Falsey, Stephanie Sproule, Merlin L. Robb, Robert W. Frenck, et al. (+17)
45 [GO] 2022―Sep―14 Lessons from a large-scale COVID-19 vaccine trial Ranjeet Singh Mahla, Lynn B. Dustin
46 [GO] 2022―Aug―31 COVID-19 vaccines protect children of all ages Justin Z. Amarin, Haya Hayek, Natasha B. Halasa
47 [GO] 2022―Aug―09 NVX-CoV2373 vaccination induces functional SARS-CoV-2-specific CD4+ and CD8+ T cell responses Carolyn Rydyznski Moderbacher, Christina J. Kim, Jose Mateus, Joyce S. Plested, Mingzhu Zhu, Shane Cloney-Clark, et al. (+5)
48 [GO] 2022―Jul―31 Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches Jasimuddin Ahamed, Jeffrey Laurence
49 [GO] 2022―Jul―14 Frequent detection but lack of infectivity of SARS-CoV-2 RNA in pre-symptomatic, infected blood donor plasma Paula Saá, Rebecca V. Fink, Sonia Bakkour, Jing Jin, Graham Simmons, Marcus O. Muench, et al. (+19)
50 [GO] 2022―May―10 Favorable vaccine-induced SARS-CoV-2 specific T cell response profile in patients undergoing immune-modifying therapies Martin Qui, Nina Le Bert, Webber Pak Wo Chan, Malcolm Tan, Shou Kit Hang, Smrithi Hariharaputran, et al. (+7)
51 [GO] 2022―Apr―28 Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response Maddalena Marconato, Irene A. Abela, Anthony Hauser, Magdalena Schwarzmüller, Rheliana Katzensteiner, Dominique L. Braun, et al. (+17)
52 [GO] 2022―Apr―26 An antibody targeting the N-terminal domain of SARS-CoV-2 disrupts the spike trimer Naveenchandra Suryadevara, Andrea R. Shiakolas, Laura A. VanBlargan, Elad Binshtein, Rita E. Chen, James Brett Case, et al. (+15)
53 [GO] 2022―Mar―22 A multitope SARS-COV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and Omicron variants Chang Yi Wang, Kao-Pin Hwang, Hui-Kai Kuo, Wen-Jiun Peng, Yea-Huei Shen, Be-Sheng Kuo, et al. (+44)
54 [GO] 2022―Mar―08 Vaccine-breakthrough infections with SARS-CoV-2 Alpha mirror mutations in Delta Plus, Iota and Omicron Brenda Martínez-González, Lucía Vázquez-Sirvent, María E. Soria, Pablo Mínguez, Llanos Salar-Vidal, Carlos García-Crespo, et al. (+13)
55 [GO] 2022―Feb―09 Streptococcus pneumoniae colonization associates with impaired adaptive immune responses against SARS-CoV-2 Elena Mitsi, Jesús Reiné, Britta C. Urban, Carla Solorzano, Elissavet Nikolaou, Angela D. Hyder-Wright, et al. (+24)
56 [GO] 2022―Feb―09 SARS-CoV-2 infection and vaccination trigger long-lived B and CD4+ T lymphocytes: implications for booster strategies Alessio Mazzoni, Anna Vanni, Michele Spinicci, Giulia Lamacchia, Seble Tekle Kiros, Arianna Rocca, et al. (+15)
57 [GO] 2022―Feb―02 Ultrapotent neutralizing antibodies against SARS-CoV-2 with a high degree of mutation resistance Jia Zou, Li Li, Peiyi Zheng, Wenhua Liang, Siyi Hu, Shuaixiang Zhou, et al. (+28)
58 [GO] 2022―Jan―21 CD4+ T-cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses Bezawit A. Woldemeskel, Arbor G. Dykema, Caroline Garliss, Saphira Cherfils, Kellie N. Smith, Joel N. Blankson
59 [GO] 2021―Dec―29 Platelets mediate inflammatory monocyte activation by SARS-CoV-2 Spike protein Tianyang Li, Yang Yang, Yongqi Li, Zhengmin Wang, Faxiang Ma, Runqi Luo, et al. (+7)
60 [GO] 2021―Dec―14 The Journal of Clinical Investigation in the time of COVID-19 Arturo Casadevall, Sarah Jackson, Gregg L. Semenza, Gordon F. Tomaselli, Rexford S. Ahima
61 [GO] 2021―Dec―14 Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. Reply. Anthony T. Tan, Nina Le Bert, Antonio Bertoletti
62 [GO] 2021―Dec―14 Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions Rory D. de Vries, Marieke van der Heiden, Daryl Geers, Celine Imhof, Debbie van Baarle
63 [GO] 2021―Dec―06 Randomized, double-blind, controlled trial of human anti-LIGHT monoclonal antibody in COVID-19 acute respiratory distress syndrome David S. Perlin, Garry A. Neil, Colleen Anderson, Inbal Zafir-Lavie, Shane Raines, Carl F. Ware, H. Jeffrey Wilkins
64 [GO] 2021―Nov―29 SARS-CoV-2-specific memory B cells can persist in the elderly who have lost detectable neutralising antibodies Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Jessica Davies, Monika Patel, et al. (+9)
65 [GO] 2021―Nov―17 A randomized controlled study of convalescent plasma for individuals hospitalized with COVID-19 pneumonia Katharine J. Bar, Pamela A. Shaw, Grace H. Choi, Nicole Aqui, Andrew Fesnak, Jasper B. Yang, et al. (+34)
66 [GO] 2021―Nov―14 Metabolic imbalance of T cells in COVID-19 is hallmarked by basigin and mitigated by dexamethasone Peter J. Siska, Sonja-Maria Decking, Nathalie Babl, Carina Matos, Christina Bruss, Katrin Singer, et al. (+40)
67 [GO] 2021―Nov―09 Family matters for coronavirus disease and vaccines David J. Bean, Manish Sagar
68 [GO] 2021―Oct―31 NK cell receptor and ligand composition influences the clearance of SARS-CoV-2 Wan-Chen Hsieh, En-Yu Lai, Yu-Ting Liu, Yi-Fu Wang, Yi-Shiuan Tzeng, Lu Cui, et al. (+22)
69 [GO] 2021―Oct―28 The intersection of COVID-19 and autoimmunity Jason S. Knight, Roberto Caricchio, Jean Laurent Casanova, Alexis J. Combes, Betty Diamond, Sharon E. Fox, et al. (+13)
70 [GO] 2021―Oct―21 Will GWAS eventually allow the identification of genomic biomarkers for COVID-19 severity and mortality? Vito Luigi Colona, Michela Bianocolella, Antonio Novelli, Giuseppe Novelli
71 [GO] 2021―Oct―08 Cross-protective immunity following coronavirus vaccination and coronavirus infection Tanushree Dangi, Nicole Palacio, Sarah Sanchez, Mincheol Park, Jake Class, Lavanya Visvabharathy, et al. (+4)
72 [GO] 2021―Oct―07 SARS-CoV-2 vaccine effectiveness in preventing confirmed infection in pregnant women Adeel A. Butt, Hiam Chemaitelly, Abdullatif Al Khal, Peter V Coyle, Huda Saleh, Anvar Kaleeckal, et al. (+4)
73 [GO] 2021―Oct―01 Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality Tomoko Nakanishi, Sara Pigazzini, Frauke Degenhardt, Mattia Cordioli, Guillaume Butler-Laporte, Douglas Maya-Miles, et al. (+41)
74 [GO] 2021―Sep―30 Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18)
75 [GO] 2021―Sep―14 Physician-scientists in the pandemic era: tidal wave or rising tide? Lorraine B. Ware
76 [GO] 2021―Sep―09 Seasonal coronavirus-specific B-cells with limited SARS-CoV-2 cross-reactivity dominate the IgG response in severe COVID-19 patients Muriel Aguilar-Bretones, Brenda M. Westerhuis, Matthijs P. Raadsen, Erwin de Bruin, Felicity D. Chandler, Nisreen M.A. Okba, et al. (+12)
77 [GO] 2021―Sep―02 A multicenter randomized open-label clinical trial for convalescent plasma in patients hospitalized with COVID-19 pneumonia Cristina Avendaño-Solá, Antonio Ramos-Martínez, Elena Muñez-Rubio, Belen Ruiz-Antorán, Rosa Malo de Molina, Ferran Torres, et al. (+31)
78 [GO] 2021―Aug―31 Convalescent plasma associates with reduced mortality and improved clinical trajectory in patients hospitalized with COVID-19 Shanna A. Arnold Egloff, Angela Junglen, Joseph S.A. Restivo, Marjorie Wongskhaluang, Casey Martin, Pratik Doshi, et al. (+6)
79 [GO] 2021―Aug―31 Results of the CAPSID randomized trial for high-dose convalescent plasma in severe COVID-19 patients Sixten Körper, Manfred Weiss, Daniel Zickler, Thomas Wiesmann, Kai Zacharowski, Victor M. Corman, et al. (+21)
80 [GO] 2021―Aug―31 Rapid measurement of SARS-CoV-2 spike T cells in whole blood from vaccinated and naturally infected individuals Anthony T. Tan, Joey M.E. Lim, Nina Le Bert, Kamini Kunasegaran, Adeline Chia, Martin D.C. Qui, et al. (+12)
81 [GO] 2021―Aug―27 Attenuated activation of pulmonary immune cells in mRNA-1273 vaccinated hamsters after SARS-CoV-2 infection Michelle Meyer, Yuan Wang, Darin Edwards, Gregory R. Smith, Aliza B. Rubenstein, Palaniappan Ramanathan, et al. (+22)
82 [GO] 2021―Aug―19 Intravenous bamlanivimab use associates with reduced hospitalization in high-risk patients with mild to moderate COVID-19 Ravindra Ganesh, Colin F. Pawlowski, John C. O'Horo, Lori L. Arndt, Richard F. Arndt, Sarah Bell, et al. (+14)
83 [GO] 2021―Aug―19 Association of in-hospital use of ACE-I/ARB and COVID-19 outcomes in African American population Shilong Li, Rangaprasad Sarangarajan, Tomi Jun, Yu-Han Kao, Zichen Wang, Ke Hao, et al. (+7)
84 [GO] 2021―Aug―17 Group IIA secreted phospholipase A2 is associated with the pathobiology leading to COVID-19 mortality Justin M. Snider, Jeehyun Karen You, Xia Wang, Ashley J. Snider, Brian Hallmark, Manja M. Zec, et al. (+18)
85 [GO] 2021―Aug―10 Dominance of alpha and Iota variants in SARS-CoV-2 vaccine breakthrough infections in New York City Ralf Duerr, Dacia Dimartino, Christian Marier, Paul Zappile, Guiqing Wang, Jennifer Lighter, et al. (+3)
86 [GO] 2021―Jul―14 Distinctive features of severe SARS-CoV-2 pneumonia G.R. Scott Budinger, Alexander V. Misharin, Karen M. Ridge, Benjamin D. Singer, Richard G. Wunderink
87 [GO] 2021―Jun―30 SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes Yijia Li, Alexis M. Schneider, Arnav Mehta, Moshe Sade-Feldman, Kyle R. Kays, Matteo Gentili, et al. (+24)
88 [GO] 2021―Jun―24 Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia Qian Zhang, Aurélie Cobat, Paul Bastard, Luigi D. Notarangelo, Helen C. Su, Laurent Abel, Jean-Laurent Casanova
89 [GO] 2021―Jun―22 Association of rare predicted loss-of-function variants of influenza-related type I IFN genes with critical COVID-19 pneumonia. Reply Gundula Povysil, Guillaume Butler-Laporte, Ali G. Gharavi, J. Brent Richards, David B. Goldstein, Krzysztof Kiryluk
90 [GO] 2021―Jun―18 Interpreting and addressing suboptimal immune responses after COVID-19 vaccination in solid organ transplant recipients Peter G. Stock, Timothy J. Henrich, Dorry L. Segev, William A. Werbel
91 [GO] 2021―Jun―08 Impaired humoral and cellular immunity after SARS-CoV2 BNT162b2 (Tozinameran) prime-boost vaccination in kidney transplant recipients Arne Sattler, Eva Schrezenmeier, Ulrike A. Weber, Alexander Potekhin, Friederike Bachmann, Henriette Straub-Hohenbleicher, et al. (+19)
92 [GO] 2021―Jun―01 Coronavirus-specific antibody production in middle-aged mice requires phospholipase A2G2D Jian Zheng, David Meyerholz, Lok-Yin Roy Wong, Michael Gelb, Makoto Murakami, Stanley Perlman
93 [GO] 2021―Jun―01 Mild COVID-19 despite autoantibodies to type I IFNs in Autoimmune-Polyendocrine-Syndrome Type 1 (APS-1) Christian Meisel, Bengisu Akbil, Tim Meyer, Erwin Lankes, Victor M. Corman, Olga Staudacher, et al. (+8)
94 [GO] 2021―Jun―01 Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19? Chris Cotsapas, Janna Saarela, Jocelyn R. Farmer, Vinod Scaria, Roshini S. Abraham
95 [GO] 2021―May―27 Rare loss-of-function variants in type I IFN immunity genes are not associated with severe COVID-19 Gundula Povysil, Guillaume Butler-Laporte, Ning Shang, Chen Wang, Atlas Khan, Manal Alaamery, et al. (+46)
96 [GO] 2021―May―21 Mounting evidence for immunizing previously infected subjects with a single dose of SARS-CoV-2 vaccine Gonzalo Perez Marc, Damian Alvarez-Paggi, Fernando P. Polack
97 [GO] 2021―May―20 Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine Ofer Beharier, Romina Plitman Mayo, Tal Raz, Kira Nahum Sacks, Letizia Schreiber, Yael Suissa-Cohen, et al. (+18)
98 [GO] 2021―May―18 Nasal ciliated cells are primary targets for SARS-CoV-2 replication in early stage of COVID-19 Ji Hoon Ahn, JungMo Kim, Seon Pyo Hong, Sung Yong Choi, Myung Jin Yang, Young Seok Ju, et al. (+8)
99 [GO] 2021―May―11 A randomized double-blind controlled trial of convalescent plasma in adults with severe COVID-19 Max R. O'Donnell, Beatriz Grinsztejn, Matthew J. Cummings, Jessica E. Justman, Matthew R. Lamb, Christina M. Eckhardt, et al. (+36)
100 [GO] 2021―May―11 What should define a SARS-CoV-2 “breakthrough” infection? John S. Schieffelin, Elizabeth B. Norton, Jay K. Kolls
101 [GO] 2021―May―06 One dose of SARS-CoV-2 vaccine exponentially increases antibodies in recovered individuals with symptomatic COVID-19 Riccardo Levi, Elena Azzolini, Chiara Pozzi, Leonardo Ubaldi, Michele Lagioia, Alberto Mantovani, Maria Rescigno
102 [GO] 2021―May―04 Relationship of SARS-CoV-2-specific CD4 response to COVID-19 severity and impact of HIV-1 and Tuberculosis co-infection Catherine Riou, Elsa Du Bruyn, Cari Stek, Remy Daroowala, Rene T. Goliath, Fatima Abrahams, et al. (+8)
103 [GO] 2021―May―04 Is complement the culprit behind COVID-19 vaccine-related adverse reactions? Dimitrios C. Mastellos, Panagiotis Skendros, John D. Lambris
104 [GO] 2021―May―03 First-dose mRNA vaccination is sufficient to reactivate immunological memory to SARS-CoV-2 in recovered COVID-19 subjects Alessio Mazzoni, Nicoletta Di Lauria, Laura Maggi, Lorenzo Salvati, Anna Vanni, Manuela Capone, et al. (+16)
105 [GO] 2021―Apr―12 SARS-CoV-2 as a superantigen in multisystem inflammatory syndrome in children (MIS-C) Theodore Kouo, Worarat Chaisawangwong
106 [GO] 2021―Apr―12 Structure-based phylogeny identifies Avoralstat as a TMPRSS2 inhibitor that prevents SARS-CoV-2 infection in mice Young Joo Sun, Gabriel Velez, Dylan E. Parsons, Kun Li, Miguel E. Ortiz, Shaunik Sharma, et al. (+3)
107 [GO] 2021―Apr―08 Functional characterization of CD4+ T-cell receptors cross-reactive for SARS-CoV-2 and endemic coronaviruses Arbor G. Dykema, Boyang Zhang, Bezawit A. Woldemeskel, Caroline C. Garliss, Laurene S. Cheung, Dilshad Choudhury, et al. (+22)
108 [GO] 2021―Apr―06 SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63 Bezawit A. Woldemeskel, Caroline C. Garliss, Joel N. Blankson
109 [GO] 2021―Mar―16 A sobering addition to the literature on COVID-19 and the brain Amit Mahajan, Graeme F. Mason
110 [GO] 2021―Feb―26 Identification of SARS-CoV-2-specific immune alterations in acutely ill patients Rose-Marie Rébillard, Marc Charabati, Camille Grasmuck, Abdelali Filali-Mouhim, Olivier Tastet, Nathalie Brassard, et al. (+32)
111 [GO] 2021―Feb―25 Long-term micro-structure and cerebral blood flow changes in patients recovered from COVID-19 without neurological manifestations Yuanyuan Qin, Jinfeng Wu, Tao Chen, Jia Li, Guiling Zhang, Di Wu, et al. (+8)
112 [GO] 2021―Feb―23 SARS-Cov2 variants and convalescent plasma: reality, fallacies, and opportunities Arturo Casadevall, Jeffrey Henderson, Michael Joyner, Liise-anne Pirofski
113 [GO] 2021―Feb―11 Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality William R. Morgenlander, Stephanie N. Henson, Daniel R. Monaco, Athena Chen, Kirsten Littlefield, Evan M. Bloch, et al. (+23)
114 [GO] 2021―Feb―11 Durable SARS-CoV-2 B cell immunity after mild or severe disease Clinton O. Ogega, Nicole E. Skinner, Paul W. Blair, Han-Sol Park, Kirsten Littlefield, Abhinaya Ganesan, et al. (+10)
115 [GO] 2021―Feb―09 Sensitive tracking of circulating viral RNA through all stages of SARS-CoV-2 infection Zhen Huang, Bo Ning, He S. Yang, Brady M. Youngquist, Alex Niu, Christopher J. Lyon, et al. (+19)
116 [GO] 2021―Feb―01 The COVID-19 immune landscape is dynamically and reversibly correlated with disease severity Hamid Bolouri, Cate Speake, David Skibinski, S. Alice Long, Anne M. Hocking, Daniel J. Campbell, et al. (+3)
117 [GO] 2021―Jan―26 Similarities and differences between the immunopathogenesis of COVID-19-related pediatric inflammatory multisystem syndrome and Kawasaki disease Ana Esteve-Sole, Jordi Anton, Rosa Maria Pino-Ramírez, Judith Sanchez-Manubens, Victoria Fumadó, Clàudia Fortuny, et al. (+17)
118 [GO] 2021―Jan―26 Severe SARS-CoV-2 placenta infection can impact neonatal outcome in the absence of vertical transmission Fulvia Milena Cribié, Roberta Erra, Lorenza Pugni, Carlota Rubio-Perez, Lidia Alonso, Sara Simonetti, et al. (+16)
119 [GO] 2021―Jan―25 Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, et al. (+16)
120 [GO] 2021―Jan―14 COVID-19 vaccine testing in pregnant females is necessary Sabra L. Klein, Patrick S. Creisher, Irina Burd
121 [GO] 2021―Jan―11 SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals Hassen Kared, Andrew D. Redd, Evan M. Bloch, Tania S. Bonny, Hermi R. Sumatoh, Faris Kairi, et al. (+16)
122 [GO] 2020―Dec―15 Clinical, laboratory, and temporal predictors of neutralizing antibodies to SARS-CoV-2 among COVID-19 convalescent plasma donor candidates Jim Boonyaratanakornkit, Chihiro Morishima, Stacy Selke, Danniel Zamora, Sarah A. McGuffin, Adrienne E. Shapiro, et al. (+19)
123 [GO] 2020―Dec―11 BCG vaccination in healthcare providers and the protection against COVID-19 Mihai G. Netea, Jos W.M. van der Meer, Reinout van Crevel
124 [GO] 2020―Nov―20 Does common cold coronavirus infection protect against severe SARS-CoV2 disease? David K. Meyerholz, Stanley Perlman
125 [GO] 2020―Nov―20 SARS-CoV-2 B cell receptor signatures in risk populations Andrew I. Flyak
126 [GO] 2020―Nov―19 BCG vaccination history associates with decreased SARS-CoV-2 seroprevalence across a diverse cohort of healthcare workers Magali Noval Rivas, Joseph E. Ebinger, Min Wu, Nancy Sun, Jonathan Braun, Kimia Sobhani, et al. (+3)
127 [GO] 2020―Nov―12 Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium Bryce A. Schuler, A. Christian Habermann, Erin J. Plosa, Chase J. Taylor, Christopher Jetter, Nicholas M. Negretti, et al. (+13)
128 [GO] 2020―Nov―10 Emergency seed funding for COVID-19 research: lessons from Johns Hopkins University Julie Messersmith, Chasmine Stoddart-Osumah, Marc Lennon, Denis Wirtz
129 [GO] 2020―Nov―02 Corticosteroid treatment in severe COVID-19 patients with acute respiratory distress syndrome Jiao Liu, Sheng Zhang, Xuan Dong, Zhongyi Li, Qianghong Xu, Huibin Feng, et al. (+14)
130 [GO] 2020―Oct―29 Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection Jacob K. Files, Sushma Boppana, Mildred D. Perez, Sanghita Sarkar, Kelsey E. Lowman, Kai Qin, et al. (+9)
131 [GO] 2020―Oct―27 Inflammatory syndromes associated with SARS-CoV-2 infection: dysregulation of the immune response across the age spectrum Jill E. Weatherhead, Eva H. Clark, Tiphanie P. Vogel, Robert L. Atmar, Prathit A. Kulkarni
132 [GO] 2020―Oct―26 Prolonged adaptive immune activation in COVID-19: implications for maintenance of long-term immunity? Philip A. Mudd, Kenneth E. Remy
133 [GO] 2020―Oct―21 Age-related susceptibility to Coronavirus infections: role of impaired and dysregulated host immunity Rudragouda Channappanavar, Stanley Perlman
134 [GO] 2020―Oct―16 SARS-CoV-2 specific antibody rearrangements in pre-pandemic immune repertoires of risk cohorts and COVID-19 patients Lisa Paschold, Donjete Simnica, Edith Willscher, Maria J.G.T. Vehreschild, Jochen Dutzmann, Daniel G. Sedding, et al. (+2)
135 [GO] 2020―Oct―15 What are protective antibody responses to pandemic SARS-CoV-2? Jeffrey P. Henderson
136 [GO] 2020―Oct―06 COVID-19 and myeloid cells: complex interplay correlates with lung severity Franco R. D'Alessio, Nicola M. Heller
137 [GO] 2020―Sep―30 Recent endemic coronavirus infection is associated with less severe COVID-19 Manish Sagar, Katherine Reifler, Michael Rossi, Nancy S. Miller, Pranay Sinha, Laura White, Joseph P. Mizgerd
138 [GO] 2020―Sep―29 COVID-19 survival associates with the immunoglobulin response to the SARS-CoV-2 spike Receptor Binding Domain Massimiliano Secchi, Elena Bazzigaluppi, Cristina Brigatti, Ilaria Marzinotto, Cristina Tresoldi, Patrizia Rovere-Querini, et al. (+7)
139 [GO] 2020―Sep―25 Corticosteroids, COVID-19 pneumonia and acute respiratory distress syndrome Michael A. Matthay, Katherine D. Wick
140 [GO] 2020―Sep―25 Are T cells helpful for COVID-19: the relationship between response and risk Diane E. Griffin
141 [GO] 2020―Sep―23 Healthy donor T-cell responses to common cold coronaviruses and SARS-CoV-2 Bezawit A. Woldemeskel, Abena K. Kwaa, Caroline C. Garliss, Oliver Laeyendecker, Stuart C. Ray, Joel N. Blankson
142 [GO] 2020―Sep―15 Drugs of unproven benefit for COVID-19: a pharma perspective on ethical allocation of available therapies Arthur L. Caplan, Joanne Waldstreicher, Karla Childers, Aran Maree
143 [GO] 2020―Sep―14 Complement and coagulation: key triggers of COVID-19-induced multiorgan pathology Berhane Ghebrehiwet, Ellinor I. Peerschke
144 [GO] 2020―Sep―09 Caring for patients in a new pandemic: the necessity and challenges of observational research David L. Thomas
145 [GO] 2020―Sep―08 Favorable outcomes of COVID-19 in recipients of hematopoietic cell transplantation Gunjan L. Shah, Susan DeWolf, Yeon Joo Lee, Roni Tamari, Parastoo B. Dahi, Jessica A. Lavery, et al. (+22)
146 [GO] 2020―Sep―01 Immune pathogenesis of COVID-19-related Multisystem Inflammatory Syndrome in Children (MIS-C) Anne H. Rowley, Stanford T. Shulman, Moshe Arditi
147 [GO] 2020―Aug―25 Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals Fang Gong, Yaping Dai, Ting Zheng, Liang Cheng, Dan Zhao, Hao Wang, et al. (+5)
148 [GO] 2020―Aug―24 SARS-CoV-2 specific T-cell responses and correlations with COVID-19 patient predisposition Arne Sattler, Stefan Angermair, Helena Stockmann, Katrin Moira Heim, Dmytro Khadzhynov, Sascha Treskatsch, et al. (+3)
149 [GO] 2020―Aug―18 Baricitinib restrains the immune dysregulation in severe COVID-19 patients Vincenzo Bronte, Stefano Ugel, Elisa Tinazzi, Antonio Vella, Francesco De Sanctis, Stefania Canè, et al. (+24)
150 [GO] 2020―Aug―12 COVID-19 severity associates with pulmonary redistribution of CD1c+ DC and inflammatory transitional and nonclassical monocytes Ildefonso Sánchez-Cerrillo, Pedro Landete, Beatriz Aldave, Santiago Sánchez-Alonso, Ana Sánchez-Azofra, Ana Marcos-Jiménez, et al. (+18)
151 [GO] 2020―Aug―07 Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population Sabra L. Klein, Andrew Pekosz, Han-Sol Park, Rebecca L. Ursin, Janna R. Shapiro, Sarah E. Benner, et al. (+17)
152 [GO] 2020―Aug―06 Complement and tissue factor-enriched neutrophil extracellular traps are key drivers in COVID-19 immunothrombosis Panagiotis Skendros, Alexandros Mitsios, Akrivi Chrysanthopoulou, Dimitrios C. Mastellos, Simeon Metallidis, Petros Rafailidis, et al. (+11)
153 [GO] 2020―Aug―03 Toward better preparedness for the next pandemic Lauren I. Shapiro, Grace R. Kajita, Julia H. Arnsten, Yaron Tomer
154 [GO] 2020―Jul―30 Multisystem inflammatory syndrome in children and COVID-19 are distinct presentations of SARS-CoV-2 Caroline Diorio, Sarah E. Henrickson, Laura A. Vella, Kevin O. McNerney, Julie M. Chase, Chakkapong Burudpakdee, et al. (+31)
155 [GO] 2020―Jul―30 COVID-19, racism, and the pursuit of health care and research worthy of trust Lisa A. Cooper, Deidra C. Crews
156 [GO] 2020―Jul―23 Distinct clinical and immunological features of SARS-COV-2-induced multisystem inflammatory syndrome in children Pui Y. Lee, Megan Day-Lewis, Lauren A. Henderson, Kevin Friedman, Jeffrey Lo, Jordan E. Roberts, et al. (+23)
157 [GO] 2020―Jul―21 Prioritizing clinical research studies during the COVID-19 pandemic: lessons from New York City Roy M. Gulick, Magdalena E. Sobieszczyk, Donald W. Landry, Anthony N. Hollenberg
158 [GO] 2020―Jul―07 Kinetics of viral load and antibody response in relation to COVID-19 severity Yanqun Wang, Lu Zhang, Ling Sang, Feng Ye, Shicong Ruan, Bei Zhong, et al. (+38)
159 [GO] 2020―Jul―07 SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy Arturo Casadevall, Michael J. Joyner, Liise-anne Pirofski
160 [GO] 2020―Jun―23 SARS-CoV-2 infection of the placenta Hillary Hosier, Shelli F. Farhadian, Raffaella A. Morotti, Uma Deshmukh, Alice Lu-Culligan, Katherine H. Campbell, et al. (+30)
161 [GO] 2020―Jun―11 Early safety indicators of COVID-19 convalescent plasma in 5,000 patients Michael J. Joyner, R. Scott Wright, DeLisa Fairweather, Jonathon W. Senefeld, Katelyn A. Bruno, Stephen A. Klassen, et al. (+30)
162 [GO] 2020―May―28 Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependent Alessio Mazzoni, Lorenzo Salvati, Laura Maggi, Manuela Capone, Anna Vanni, Michele Spinicci, et al. (+23)
163 [GO] 2020―May―28 New York City COVID-19 resident physician exposure during exponential phase of pandemic Mark P. Breazzano, Junchao Shen, Aliaa H. Abdelhakim, Lora Dagi Glass, Jason Horowitz, Sharon X. Xie, et al. (+3)
164 [GO] 2020―May―27 COVID-19, microangiopathy, hemostatic activation, and complement Wen-Chao Song, Garret A. FitzGerald
165 [GO] 2020―May―11 Clinical trials for COVID-19 should include sex as a variable Evelyne Bischof, Jeannette Wolfe, Sabra L. Klein
166 [GO] 2020―Apr―30 Preventing cytokine storm syndrome in COVID-19 using α-1 adrenergic receptor antagonists Maximilian F. Konig, Michael A. Powell, Verena Staedtke, Ren-Yuan Bai, David L. Thomas, Nicole M. Fischer, et al. (+12)
167 [GO] 2020―Apr―30 Prototype pathogen approach for pandemic preparedness: world on fire Barney S. Graham, Kizzmekia S. Corbett
168 [GO] 2020―Apr―24 Panic prescribing has become omnipresent during the COVID-19 pandemic Arthur L. Caplan, Ross Upshur
169 [GO] 2020―Apr―07 Deployment of convalescent plasma for the prevention and treatment of COVID-19 Evan M. Bloch, Shmuel Shoham, Arturo Casadevall, Bruce S. Sachais, Beth Shaz, Jeffrey L. Winters, et al. (+21)
170 [GO] 2020―Apr―06 Kidney diseases in the time of COVID-19: major challenges to patient care Hamid Rabb
171 [GO] 2020―Apr―03 The COVID-19 pandemic and research shutdown: staying safe and productive M. Bishr Omary, Jeetendra R. Eswaraka, S. David Kimball, Prabhas V. Moghe, Reynold A. Panettieri, Jr., Kathleen W. Scotto
172 [GO] 2020―Mar―30 COVID-19 threatens health systems in sub-Saharan Africa: the eye of the crocodile Elijah Paintsil
173 [GO] 2020―Mar―27 Clinical and immunologic features in severe and moderate Coronavirus Disease 2019 Guang Chen, Di Wu, Wei Guo, Yong Cao, Da Huang, Hongwu Wang, et al. (+14)
174 [GO] 2020―Mar―27 SARS-CoV-2: A Storm is Raging Savannah F. Pedersen, Ya-Chi Ho
175 [GO] 2020―Mar―22 Changing the editorial process at JCI and JCI Insight in response to the COVID-19 pandemic Rexford S. Ahima, Sarah Jackson, Arturo Casadevall, Gregg L. Semenza, Gordon Tomaselli, Kathleen L. Collins, et al. (+3)
176 [GO] 2020―Mar―13 The convalescent sera option for containing COVID-19 Arturo Casadevall, Liise-anne Pirofski
 [1] 

176 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec